Cite
HARVARD Citation
Passaro, A. et al. (n.d.). 144PClinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Passaro, A. et al. (n.d.). 144PClinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs. Annals of oncology. p. . [Online].